Status:
UNKNOWN
Lymphocyte Counts in Immune Thrombocytopenic Purpura
Lead Sponsor:
Assiut University
Conditions:
Thrombocytopenic Purpura
Eligibility:
All Genders
Brief Summary
* immune thrombocytopenic purpura is an acquired autoimmune disorder characterized by increased platelet destruction and decreased platelet number (cooper N et al 2006) * recent studies have demonstra...
Detailed Description
Immune thrombocytopenic purpura is an acquired autoimmune disorder characterized by increased platelet destruction and decreased platelet number ( Cooper N et all 2006) platelet surface membrane prote...
Eligibility Criteria
Inclusion
- Newly diagnosed cases of primary ITP , adults and children.
Exclusion
- Cases of secondary ITP
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03244410
Start Date
October 1 2017
End Date
January 1 2019
Last Update
August 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.